Patent 7932062 was granted and assigned to deVGen NV on April, 2011 by the United States Patent and Trademark Office.
Improved vector constructs useful in the expression of double-stranded RNA are provided. The constructs are particularly useful for expression of double-stranded RNA in vitro and in vivo.